VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 536 filers reported holding VANECK VECTORS ETF TR in Q4 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $285,000 | -12.6% | 9,665 | +0.7% | 0.03% | -11.1% |
Q2 2021 | $326,000 | +7.2% | 9,599 | +2.6% | 0.04% | -20.0% |
Q1 2021 | $304,000 | +12.6% | 9,355 | +25.0% | 0.04% | -6.2% |
Q4 2020 | $270,000 | -7.5% | 7,484 | +0.3% | 0.05% | -21.3% |
Q3 2020 | $292,000 | +14.5% | 7,464 | +14.5% | 0.06% | +10.9% |
Q2 2020 | $255,000 | +25.6% | 6,519 | +9.7% | 0.06% | +1.9% |
Q1 2020 | $203,000 | +118.3% | 5,945 | +82.3% | 0.05% | +145.5% |
Q4 2019 | $93,000 | – | 3,261 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
Brown University | 541,096 | $19,490,000 | 14.10% |
Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |